Key facts
- Jorey Chernett filed SCHEDULE 13G/A for OKYO Pharma Ltd Common (OKYO).
- Disclosed ownership: 9.5%.
- Date of event: 31 Dec 2025.
Jorey Chernett - 31 Dec 2025 SCHEDULE 13G/A Report for OKYO Pharma Ltd Common (OKYO)
- Filing Manager
- Jorey Chernett
- Reporting Manager
- Chernett Jorey
- Security
- OKYO Pharma Ltd Common
- Symbol
- OKYO
- Shares outstanding
- 40,023,095 shares
- Disclosed Ownership
- 3,802,194 shares
- Ownership
- 9.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Feb 2026, 17:08:38 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Nov 2025
- SEC
- View on sec.gov
Key filing fact
Jorey Chernett disclosed 9.5% ownership in OKYO Pharma Ltd Common (OKYO) on 31 Dec 2025.
Change
- Previous schedule filing date: 14 Nov 2025.
- Current filing was accepted on 13 Feb 2026, 17:08.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Chernett Jorey | 9.5% | 3,802,194 | 3,802,194 | 0 | /s/Jorey Chernett | Individual |
CIK / CUSIP context first